Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Medical Cannabis and Cannabinoids
|
October 22, 2021
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Paul T Kocis, Kent E Vrana
Medical Cannabis and Cannabinoids
|
August 15, 2024
Cannabinoid Awareness, Reporting Use to Health Care Providers, and Perceptions Regarding Safety - Pennsylvania, March 2023-April 2023
Paul T Kocis, Daniel J Mallinson, Timothy J Servinsky
JMIR Formative Research
|
October 24, 2024
The Perspectives of Community Pharmacists Toward the Name-Based Rationing System During the COVID-19 Pandemic in Taiwan: Cross-Sectional Survey Study
En-Ling Chen, Chyi-Huey Bai, Paul T Kocis, et al.
International Journal of Endocrinology and Metabolism
|
November 23, 2018
Comparison of Osteoporosis Pharmacotherapy Fracture Rates: Analysis of a MarketScan<sup>®</sup> Claims Database Cohort
Alan W Reynolds, Guodong Liu, Paul T Kocis, et al.
Medical Cannabis and Cannabinoids
|
February 23, 2023
CANNabinoid Drug Interaction Review (CANN-DIR™)
Paul T Kocis, Samuel Wadrose, Ryan Lee Wakefield, et al.
Drugs - Real World Outcomes
|
July 12, 2016
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Paul T Kocis, Guodong Liu, Dinara Makenbaeva, et al.
Frontiers in Pharmacology
|
June 13, 2024
Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and <i>Cannabis</i>
Rahul Nachnani, Amy Knehans, Jeffrey D Neighbors, et al.
BMJ Open
|
December 29, 2022
Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C)
Olga V Kravchenko, Richard D Boyce, Ainhoa Gomez-Lumbreras, et al.
Annals of Internal Medicine
|
August 16, 2021
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study
Hemalkumar B Mehta, Huijun An, Kathleen M Andersen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Medical Cannabis and Cannabinoids
|
October 22, 2021
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Paul T Kocis, Kent E Vrana
Medical Cannabis and Cannabinoids
|
August 15, 2024
Cannabinoid Awareness, Reporting Use to Health Care Providers, and Perceptions Regarding Safety - Pennsylvania, March 2023-April 2023
Paul T Kocis, Daniel J Mallinson, Timothy J Servinsky
JMIR Formative Research
|
October 24, 2024
The Perspectives of Community Pharmacists Toward the Name-Based Rationing System During the COVID-19 Pandemic in Taiwan: Cross-Sectional Survey Study
En-Ling Chen, Chyi-Huey Bai, Paul T Kocis, et al.
International Journal of Endocrinology and Metabolism
|
November 23, 2018
Comparison of Osteoporosis Pharmacotherapy Fracture Rates: Analysis of a MarketScan<sup>®</sup> Claims Database Cohort
Alan W Reynolds, Guodong Liu, Paul T Kocis, et al.
Medical Cannabis and Cannabinoids
|
February 23, 2023
CANNabinoid Drug Interaction Review (CANN-DIR™)
Paul T Kocis, Samuel Wadrose, Ryan Lee Wakefield, et al.
Drugs - Real World Outcomes
|
July 12, 2016
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Paul T Kocis, Guodong Liu, Dinara Makenbaeva, et al.
Frontiers in Pharmacology
|
June 13, 2024
Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and <i>Cannabis</i>
Rahul Nachnani, Amy Knehans, Jeffrey D Neighbors, et al.
BMJ Open
|
December 29, 2022
Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C)
Olga V Kravchenko, Richard D Boyce, Ainhoa Gomez-Lumbreras, et al.
Annals of Internal Medicine
|
August 16, 2021
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study
Hemalkumar B Mehta, Huijun An, Kathleen M Andersen, et al.
Page
of 1